21
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

High Performance Liquid Chromatographic Determination of Physostigmine and Its Degradation Products in Pharmaceutical Dosage Forms

&
Pages 673-683 | Published online: 23 Oct 2006

References

  • Hoover , J. E. , ed. Remington's Pharmaceutical Sciences, , 14th Ed. , 905 Easton, PA : Mack Printing Co. . 10842
  • Davis , K. L. , Mohs , R. C. and Tinklenker , J. 1979 . Enhancement of Memory by Physostigmine . New Eng. J. Med. , 301 : 946c
  • De Wildt , D. J. , Porsius , A. J. and van Rooy , H. H. 1981 . Quantitative Determination of the Cholinesterase Inhibitor Physostigmine in Brain Tissue Samples Using Reversed-Phase High-Performance Liquid Chromatography . J. Chromatogr. , 225 : 381
  • 1980 . The United States Pharmacopeia, Twentieth Revision , Rockville, Md. : United States Pharmacopeial Convention, Inc. . Mack Publishing Co., Easton, PA. 10842, Physostigmine Salicylate Injection, p. 624, Physostigmine Sulfate Ophthalmic Solution and Physostigmine Sulfate Ophthalmic Ointment, p. 625
  • Fletcher , G. and Davies , D. J. G. 1968 . The Effect of pH and Sodium Metabisulphite on the Stability of Physostigmine Sulphate Solutions to Heat and Ionizing Radiation . J. Pharm. Pharmacol. , 20 : 1085
  • Tymes , N. W. 1982 . High Pressure Liquid Chromatographic Determination of Physostigmine Salicylate and Physostigmine Sulfate in Liquids and Ointments: A Collaborative Study . J. Ass. Off. Anal. Chem. , 68 : 132
  • 1985 . The United States Pharmacopeia, Twenty-first Revision , Rockville, Md. : United States Pharmacopeial Convention, Inc. . Mack Publishing Co., Easton, PA. 18042, Physostigmine Salicylate Injection, p. 1878 and Physostigmine Sulfate Ophthalmic Ointment, p. 1979, Second Supplement
  • Salway , A. H. 1912 . Researches on the Constitution of Physostigmine . J. Chem. Soc. , 101 : 978
  • Ellis , S. 1943 . Studies on Physostigmine and Related Substances IV. Chemical Studies on Physostigmine Breakdown Products and Related Epinephrine Derivatives . J. Pharm. Expt. Ther. , 79 : 364

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.